sovietrx beta

chonluten

A synthetic tripeptide (Glu-Asp-Gly), the N-terminal of Epitalon, studied mainly as a respiratory-tissue proliferotrope in organotypic culture.

Bioregulator · Khavinson school · Glu-Asp-Gly (EDG)

identity
sequence

Glu · Asp · Gly


code EDG line bioregulator school Khavinson
Archive sequence label. Residue order as used in this dossier. No clinical structure claim.

Key takeaways

What it is

Chonluten is Glu-Asp-Gly, the N-terminal tripeptide of Epitalon (AEDG), sold in the same dietary-supplement tradition that followed peptide characterisation work.

It is the clearest “fragment of a famous peptide” story in this archive’s bioregulator line.

We feature it because the respiratory organotypic-culture programme gives a tight experimental focus with a tight experimental focus on organotypic respiratory models.

What the literature describes

Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.

Respiratory organotypic proliferation

Rat organotypic cultures of lung, bronchial artery, and bronchus report EDG / chonluten stimulating cell proliferation; combinations with other short peptides are also described.

Russian full text

Bronchial-epithelium gene-expression neighbours

Related bronchial-epithelium culture work (AEDL and neighbour peptides) discusses gene-expression and transcription-factor readouts in aging cell models.

PubMed

THP-1 inflammatory regulation assays

Human monocytic THP-1 assays evaluate inflammatory regulation by chonluten among other short peptides.

PubMed

Histone-binding biophysics (adjacent context)

Biophysical papers report short peptides binding histone N-terminal regions. Adjacent mechanism context. No respiratory-disease claim on this page.

PubMed

Research trail

Primary proliferation literature is concentrated in Russian physiology journals (Chalikova and related groups). that organotypic programme is the location of the archive for this compound.

PubMed adds a few peptide-family and inflammation titles that sit beside that programme.

Open limits

Russian full-text papers

Open-access Russian academic PDFs on CyberLeninka where we have them.

4 curated · off-topic vezugen / GI-injury / generic antioxidant rows removed

Still open

Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.

← back to the beta landing page